Local and systemic regulation of hematopoietic stem cells by thrombopoietin
Local and systemic regulation of hematopoietic stem cells by thrombopoietin
批准号:
9328520
负责人:
Matthew Decker
金额:
$4.4万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2021-06-30
关键词:
AddressAdultAlpha CellBiological AssayBlood CellsBlood PlateletsBone MarrowBone Marrow CellsBone Marrow DiseasesBone Marrow TransplantationCell CommunicationCell CountCell LineageCell MaintenanceCell physiologyCellsCellular biologyClinicalCytokine SignalingDevelopmentDiscontinuous CapillaryFailureGene ExpressionHematological DiseaseHematopoiesisHematopoieticHematopoietic SystemHematopoietic stem cellsHepatocyteInterleukin-3LeadLifeLiverMedicalMegakaryocyte ProliferationMegakaryocytopoiesesMusOsteoblastsPancytopeniaPatternPhenotypePlayPopulationProceduresProductionRegulationReporterRoleSignal TransductionSourceStem Cell FactorStromal CellsTestingTherapeuticThrombopoietinTissuesTransplantationVenousVirusbonecdc Genescell typeclinical developmentcytokineexperimental studyin situ imagingin vivoloss of functionmouse modelnovelprogenitorself renewing cellself-renewaltherapy development
中文摘要
项目摘要:
造血干细胞(HSCs)是一种重要而罕见的细胞群,可以自我调节,
广泛更新并产生所有的血细胞谱系。维持HSC,
通过外在调节调节整个生命;这种调节的破坏可能导致
HSC的损失和造血功能衰竭。因此,理解HSC的外在调节
机制具有重要的治疗意义。血小板生成素(TPO)是一种
造血细胞因子被公认为巨核细胞驱动因子
增殖和血小板生成,但也被证明是HSC所需的
上维护然而,由于TPO是在骨髓、肝脏和其他组织中产生的,
组织中,局部和全身TPO对HSC功能的相对贡献仍然是
未知本项目旨在通过使用TPO在HSC生物学中的体内作用来表征TPO的特征。
两种新的小鼠模型,允许识别骨中的TPO+群体
骨髓,以及从选择的组织中有条件地缺失Tpo。这个实验
该提案将定义TPO在HSC生物学中的作用,并对以下方面产生重大影响:
利用我们对HSC调控的新认识,
在局部因素和系统因素之间取得平衡。
英文摘要
Project Summary:
Hematopoietic stem cells (HSCs) are a critical and rare population of cells that can self-
renew extensively and produce all blood cell lineages. HSCs are maintained and
regulated throughout life by extrinsic regulation; disruption of this regulation can lead to
loss of HSCs and hematopoietic failure. Thus, understanding HSC extrinsic regulatory
mechanisms has important therapeutic implications. Thrombopoietin (TPO) is a
hematopoietic cytokine that is canonically understood as a driver of megakaryocyte
proliferation and platelet production, but has also been shown to be required for HSC
maintenance. However, since TPO is made in the bone marrow, the liver and other
tissues, the relative contributions of local and systemic TPO to HSC function are still
unknown. This project aims to characterize the in vivo role of TPO in HSC biology by use
of two novel mouse models that allow identification of TPO+ populations in the bone
marrow, and conditional deletion of Tpo from select tissues. The experiments in this
proposal will define the role of TPO in HSC biology, and have major implications for
clinical therapies that take advantage of our novel understanding of how HSC regulation
is balanced between local and systemic factors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金